The Efficacy and Safety of ITF2357 in AIS
NCT00442182
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Autoinflammatory Syndromes
HIDS
TRAPS
Schnitzler's Syndrome
Interventions
DRUG:
ITF2357
Sponsor
Radboud University Medical Center